Dr Reddy's slumps 7% on US FDA's 'severe' observations for T

Antique Broking estimates the Bachupally unit contributes nearly 30 percent to Dr Reddy's US revenue and adverse observations could lead to a warning letter

Related Keywords

Hyderabad , Andhra Pradesh , India , Telangana , , National Stock Exchange , Drug Administration , Antique Broking , National Stock , Dr Reddy S , Uzzing Stocks , S Fda , Achupally Unit , S Fda Observations , Pharma Company , Dharma , Drugmaker ,